英和和英

出典:『Wikipedia』 (2011/03/06 14:58 UTC 版)

英語による解説

引用

The Project Bioshield Act was an act passed by the United States Congress in 2004 calling for $5 billion for purchasing vaccines that would be used in the event of a bioterrorist attack. This was a ten-year program to acquire medical countermeasures to biological, chemical, radiological and nuclear agents for civilian use. A key element of the Act was to allow stockpiling and distribution of vaccines which had not been tested for safety or efficacy in humans, meaning that they need not comply with minimum FDA standards for medical use.